SJR: 0.164 SNIP: 0.041 CiteScore™: 0.18
ISSN Print: 2151-8017
Archives: Volume 1, 2010 to Volume 7, 2016
Volumes:Volume 7, 2016 Volume 6, 2015 Volume 5, 2014 Volume 4, 2013 Volume 3, 2012 Volume 2, 2011 Volume 1, 2010
Forum on Immunopathological Diseases and Therapeutics
NF-κB and Rheumatoid Arthritis: Will Understanding Genetic Risk Lead to a Therapeutic Reward?
University of Colorado Denver, School of Pharmacy, Department of Pharmaceutical Sciences, Aurora, CO 80045
NF-κB has long been known to play an important role in autoimmune diseases such as rheumatoid arthritis (RA). Indeed, as our understanding of how NF-κB is utilized has increased, we have been hard put to find a process not associated with this transcription factor family in some way. However, new data originating, in part, from genome-wide association studies have demonstrated that very specific alterations in components of the NF-κB pathway are sufficient to confer increased risk of developing disease. Here we review the data which have identified specific components of the NF-κB pathway, and consider what is known of their mechanisms of action and how these mechanisms might play into the disease process. In addition, the use of genetic information to predict RA is considered.
KEY WORDS: NF-κB, ubiquitin, A20, TNFAIP3, TRAF, REL, single nucleotide polymorphism (SNP), genome-wide association study (GWAS), rheumatoid arthritis (RA)
|Begell Digital Portal||Begell Digital Library||eBooks||Journals||References & Proceedings||Research Collections|